Following ECHA’s announcement that all meetings, including meetings of formal ECHA bodies, with external participants from abroad should be held remotely, or cancelled, until further notice...
ECHA uploaded information on several substances in its “Registry of Intentions until outcome”, mostly archiving: the uploading of submitted documents from previous consultations.
ECHA opened a public consultation on the CLH report for mepiquat-chloride on 31.03.2020.
On 23.03.2020 ECHA opened a public consultation on the CLH report for foramsulfuron.
ECHA opened a 2-week public targeted consultation on the classification of daminozide, on 16.03.2020.
ECHA published the RAC opinion on clomazone, adopted in the RAC 50 meeting of September 2019.
On 19.02.2020 ECHA published the minutes of the RAC 51 meeting of 28.11 – 05.12.2019.
On 06.02.2020 ECHA opened a targeted consultation on the classification of isoflucypram.
On 03.02.2020 ECHA opened a public consultation on the CLH report for valifenalate.
On 25.11.2019 ECHA opened a public consultation on the classification of Margosa extract.
On 28.10.2019 ECHA opened a consultation on the proposed classification for bentazone.
The ECHA “Registry of CLH intentions until outcome” published an intention from Italy to submit a CLH report for metiram.
The first compliance date for harmonised reporting to poison centres will be postponed from 1 January 2020 to 1 January 2021.
ECHA initiated a public consultation on the proposed classification for isopyrazam.
On 03.09.2019 Germany submitted a CLH proposal for diuron to ECHA.
On 26.08.2019 Czech Republic notified an intention to submit a CLH report on malathion.
On 12.08.2019 ECHA initiated a public consultation on the CLH report for fluopicolide.
On 29.07.2019 the Netherlands notified an intention to submit a CLH report on pyriproxyfen.
On 24.07.2019 ECHA initiated a public consultation on the CLH report for daminozide.
On 24.07.2019 ECHA initiated a public consultation on the CLH report for clofentezine.